• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

140 Blue Cross Blue Shield of Minnesota Employees Are Volunteering as Contact Tracers

Article

More than 140 Blue Cross and Blue Shield of Minnesota employees are starting the process this week to work as volunteer contact tracers for the Minnesota Department of Health, according to a company press release.

All the volunteers will receive training from the health department on proper protocols for conducting interviews that adhere to all laws and regulations pertaining to private and confidential health information, said the press release. Volunteers will be asked to complete a minimum two-week commitment, consisting of six-hour shifts, three to four days per week. The goal will be for volunteers to complete approximately five case calls per shift.

Minnesota has had 757 COVID-19-related deaths and 10,764 of its residents have recovered from the disease, according to the Johns Hopkins COVID-19 dashboard.

The volunteer effort is the result of Blue Cross reaching out to state health officials and offering support for the state's goal of deploying close to 500 volunteer contact tracers by the end of the month, according to the press release. "Our hope in this crisis is to offer stability and support for our communities and our state however we can," Craig Samitt, M.D., president and CEO of Blue Cross and Blue Shield of Minnesota, said in the press release.

States are taking a variety of approaches to creating contact tracing workforces. California has partnered with University of California, San Francisco. New York Gov. Andrew Cuomo has announced a plan to hire between 6,400 and 17,000 contact tracers with the support of Bloomberg Philanthropies, the charitable organization created by former New York City Mayor Mike Bloomberg.

Related Videos
Video 3 - "In-Office Procedures, Over-the-Counter Options, Treatment Delays, and Costs"
Video 6 - "Safety Analysis and Interpreting Results from MAJIC-PV"
Video 5 - "Key Findings from MAJIC-PV"
Video 2 - "Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%"
Gabriela Hobbs, MD, an expert on polycythemia vera
Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Related Content
© 2024 MJH Life Sciences

All rights reserved.